Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis - Wikidata - awgldk - TriplyDB

Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis

Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis

http://www.wikidata.org/entity/Q34405301

about

Review of vancomycin-induced renal toxicity: an update Gentamicin pharmacokinetics and pharmacodynamics during short-daily hemodialysis.A stepwise approach for the management of poisoning with extracorporeal treatments.The Nephrotoxicity of Vancomycin

P2860

Q26746932-6F8F5C1F-B5E0-4FC1-9358-26D2E0B0BF1C Q35001792-ACAF1D67-1F44-4540-AEFF-EBC6FDE0CD24 Q38201803-3A191B6B-F726-43E7-9FDE-59C2939DECEF Q38687487-94DA3CA8-4A18-4A6F-8B76-A1F25ADB1E25

P2860

Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis

http://www.wikidata.org/entity/Q34405301

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis

@ast

Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis

@en

Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis

@nl

type

label

Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis

@ast

Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis

@en

Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis

@nl

prefLabel

Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis

@ast

Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis

@en

Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis

@nl

P1433

Q34405301-F67E215D-0213-47D3-84DE-1D36DD0D8BDA

P1476

Q34405301-383C9155-FD2B-458C-988B-6365CE522ABA

P2093

Q34405301-61023718-DFBB-44CA-A0EB-E7408FD314D3

Q34405301-6F90D96A-42CB-44DB-A3BE-EDAB7A9905BE

Q34405301-99B5E96F-6E11-430C-8C8A-8BA02A5D688B

Q34405301-D05A44A6-2B03-4F20-8635-B96BA3793F57

Q34405301-D71AADC3-B050-4D3B-8071-CEEF0CC31E9D

Q34405301-FB9CA701-CB4A-46A9-833D-23C2A791A4EF

P2860

Q34405301-0AB028AA-5C42-4D44-80D0-28BADD74A44F

Q34405301-0CED3823-2D65-43DA-B235-467C210D2563

Q34405301-1063CC5C-1E1A-449A-BA76-CA6C16D929E2

Q34405301-13A49DC3-6F0D-48C4-B481-3413E56AB1D0

Q34405301-19A61F69-D16E-41A3-8363-CCCC5FCBEFE1

Q34405301-2241DABE-C5C7-4DF8-AD74-004BA70E0557

Q34405301-244847BB-7225-4E37-B201-B3E8B2817733

Q34405301-31AEDA37-258B-45AB-BB02-E2347C882316

Q34405301-58AAC5D9-24EA-4842-A393-BEBDC5F7B287

Q34405301-63C22979-26B3-4DE4-88B8-A0086EC76EA5

P304

Q34405301-C2CFC2F5-C033-442B-8161-5C77406A3002

P31

Q34405301-363D48B4-94EB-4E4D-A777-999F51BAF756

P356

Q34405301-FCDD2EA3-8FB1-4ED6-AECB-39EB2F991764

P433

Q34405301-FA6DE56E-2EC8-4461-A2A4-72EFE3F45ADA

P478

Q34405301-577AF819-BCEB-4E4C-BF67-4E789B20F6F5

P577

Q34405301-410451F9-6886-4140-9719-43674268BF17

P698

Q34405301-5457A867-55D6-4A55-B80F-936DE850B069

P932

Q34405301-EF5691DA-55B7-434B-9CDE-DF4F29CBE2F4

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis

@en

P2093

Brian S Decker

http://www.w3.org/2001/XMLSchema#string

Kevin M Sowinski

http://www.w3.org/2001/XMLSchema#string

Mary Chambers

http://www.w3.org/2001/XMLSchema#string

Michael A Kraus

http://www.w3.org/2001/XMLSchema#string

Michael B Kays

http://www.w3.org/2001/XMLSchema#string

Sharon M Moe

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical review: use of vancomycin in haemodialysis patients

Predicting treatment dose for novel therapies using urea standard Kt/V

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007

Dialysis Surveillance Report: National Healthcare Safety Network (NHSN)-data summary for 2006.

Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know.

Clinical outcome of daily dialysis.

Staphylococcus aureus resistant to vancomycin--United States, 2002.

Quotidian dialysis--update 2005.

Daily hemodialysis: challenges and opportunities in the delivery and financing of end-stage renal disease patient care.

Daily hemodialysis: an update.

P304

1981-1987

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.03450410

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20616157

http://www.w3.org/2001/XMLSchema#string

P932

3001762

http://www.w3.org/2001/XMLSchema#string